Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. - Wikidata - wikimedia - TriplyDB

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.

http://www.wikidata.org/entity/Q34937231

about

Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic Infection Interferon-alpha, immune activation and immune dysfunction in treated HIV infection A Review of Management of Inflammation in the HIV Population Cardiovascular Complications of HIV-Associated Immune Dysfunction Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada Effects of laboratory data exchange in the care of patients with HIV.High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa Microbial translocation and cardiometabolic risk factors in HIV infection.Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients.Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.Effect of early versus deferred antiretroviral therapy for HIV on survival.When to start antiretroviral therapy Prevalence, trend and risk factors for antiretroviral therapy discontinuation among HIV-infected adults in Ethiopia in 2003-2015 The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology Trend of CD4+ Cell Counts at Diagnosis and Initiation of Highly Active Antiretroviral Therapy (HAART): Korea HIV/AIDS Cohort Study, 1992-2015 Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia.Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.Functional cure of SIVagm infection in rhesus macaques results in complete recovery of CD4+ T cells and is reverted by CD8+ cell depletion.Residual immune dysregulation syndrome in treated HIV infection.Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti Short-course antiretroviral therapy in primary HIV infection.Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study.HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa.Dysregulation of multiple inflammatory molecules in lymph node and ileum of macaques during RT-SHIV infection with or without antiretroviral therapy Immune activation and HIV persistence: implications for curative approaches to HIV infection.Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection The economic burden of late entry into medical care for patients with HIV infection.Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort.Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells.HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.

P2860

Q26775036-AE8FEE27-B3CE-48DC-8821-22829F21EEFE Q26861003-1AF7CA30-16D1-4A8A-8AE8-DF2F8CB5FCE4 Q28078962-641D581E-F9DC-4DB7-872B-8942CC251708 Q28084981-9042E90A-EB74-471D-8CE6-474C2A01BD1D Q28476094-4979A7A5-013E-4DC0-BA93-1A72F9852AE9 Q28477797-1CCD7AD9-7E06-4037-87E9-F990814A2420 Q28539369-CDE23F9F-8731-449D-BE9B-B9DE8CDD9B45 Q28610686-0A6A7F3F-BCCC-4D3C-B87E-7E4C6A2328DC Q30558425-F87628EA-D1DB-464C-85EE-C08D0AB1F747 Q30999041-D25FA90E-F0F3-45D5-86C3-A80F7EC60AB3 Q33432729-2695363F-9011-42E7-BE90-2086CCE75358 Q33580153-7CDD9486-A9EE-434C-BCA8-29CA59DAA215 Q33713895-838DAA0E-8C51-4F7F-BAE8-4675929B7E19 Q33760657-E3B9AF1E-3C0A-48FE-9D44-1EAD4770EAD3 Q33781469-B9FC7A99-E7E0-4C0A-A413-D14BD54D7F98 Q33789114-615123F7-BC2A-41BB-AC52-631CC6EB7101 Q33799012-D0515ED2-6F43-4DA0-B207-716F9868B338 Q33807108-D3B6F634-5851-4C5D-AB0A-C087B3C09D0C Q33813372-8A568995-71B3-4F34-A913-8BD4F473BE70 Q33827819-AAE087DF-5A3E-4F62-95B6-95196F763F87 Q33880384-12411182-1E5F-45BC-BA53-0DB0C84A256B Q33909241-1A0F24F0-57C5-4375-A112-48145F273E4B Q33916321-BC97FEC7-95A1-4402-8F73-ECABD3959F72 Q33933071-6725FB5F-E37F-44CB-B992-A2D9EF1A6F88 Q33987485-7E150B6A-4C5C-4462-98BD-0B438574ED5E Q34020121-512A5AE8-F8A3-4D6A-9624-B071D17D003E Q34031173-40DCA668-0929-4008-9D78-6C38D05B86C5 Q34037516-A102DBB1-7F6F-4FAD-8FDC-175472988BB8 Q34065045-173B0433-D0BB-41AD-A351-8127E7EA8ED8 Q34140484-22538A5C-A827-47CA-887C-5083BE1471CB Q34170487-432FB474-DF71-45B7-919B-2CE31B89378D Q34250336-D97E8C32-2709-4EB4-B577-784E1F2FE3EF Q34351320-3F0269D5-68AA-457A-B8A1-94B0ED4F844A Q34385049-1FAB4278-C69E-4115-A011-C7EA9A100B6D Q34477711-ECB2BA14-2C95-47AD-B4F9-3AA72F10EFD5 Q34497355-CDB7661B-B56E-462A-BE4A-5A384C96A669 Q34569335-4F55E61E-A5C6-4345-9E80-33398D43B443 Q34600441-BA0CA51C-7392-4555-8B3C-8C5E9EDD8E41 Q34625399-5E85C6E6-2BCD-423C-8692-46C7F723D5AB Q34666498-BBB48506-FCC9-44CF-9BD9-0ED29A987E6C

P2860

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.

http://www.wikidata.org/entity/Q34937231

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@ast

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@en

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@nl

type

label

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@ast

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@en

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@nl

prefLabel

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@ast

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@en

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@nl

P1433

Q34937231-61B8F1FC-F7FA-46B2-9C61-54A8DEFBC5FA

P1476

Q34937231-6EF6B3AD-9622-45A1-A976-530DEEDFEFCD

P2093

Q34937231-0C23314F-E99E-490A-A50C-66AB3D4EC41E

Q34937231-440D7E53-1B0E-41ED-98A4-5819E821D898

Q34937231-4DFBBC01-C7C2-4E78-9057-492DDC57660C

Q34937231-6C9720ED-E6AB-41A0-860C-0845F2C8830A

Q34937231-BDDB639C-6086-41A0-A639-2B270B0B3228

Q34937231-C1DBCBF1-ABD4-4160-95BF-9A372048784E

Q34937231-D9464F08-543F-4E50-8829-7FE46DE509C5

Q34937231-E7427C67-5030-420B-978E-CDA8FEF07CF1

Q34937231-EA2A5860-770E-4E52-9ED4-CC2306A46AD8

P2860

Q34937231-00D1F2F1-3A18-4C31-B119-846A04BAE014

Q34937231-074CB88F-9664-49C0-B6A6-0F8DF300D68A

Q34937231-0EF212DD-C62E-4404-9596-9D21BC9EF529

Q34937231-0EF6565C-4EF1-4F6F-9ED0-0136657B82ED

Q34937231-18F41F27-BABD-4B76-BA65-62798144C66B

Q34937231-1B5D4052-09B9-4229-B8CF-03DD2399FF79

Q34937231-28BDBB07-E9B6-4A77-B93E-B667EEE8A36D

Q34937231-2EF89D1F-6BA8-4A57-A71A-3F7EF7833559

Q34937231-4F26B71E-9F42-436C-AA57-8D5B5F12FA80

Q34937231-5ACE41DA-7B32-4880-A268-EA7CB24B2FA2

P304

Q34937231-4B971A43-B74F-4B68-8179-5256B0B97594

P31

Q34937231-F3A6263F-7712-4CBA-A49B-8C1928B3C4C2

P356

Q34937231-1F835E26-CB4B-4AD7-AB31-1CD26F89F39E

P407

Q34937231-4ED777A3-6D19-4F5E-BF45-31665B647764

P433

Q34937231-1D7427B2-F764-443E-9BDE-E4C70407C3CA

P478

Q34937231-6EEC2C2B-318C-4B93-B619-B334E3BE8D30

P50

Q34937231-0C2602BE-B56F-4D0E-AACB-51DAB9638468

Q34937231-5F87A9BE-F77B-4A0F-BA15-07DBE642465F

Q34937231-CC004375-0F41-49F3-B1E8-9CF5133A8EDB

P577

Q34937231-E6FE8741-E086-4642-A264-4E4C1D8E2A09

P5875

Q34937231-7AD1F859-3FC6-421A-AC3B-B28A9060DEAC

P698

Q34937231-8CFF09D5-2FDB-4DDA-8109-DD01D05235C2

P921

Q34937231-F85AD86E-DF7E-47E4-B4DF-BD35A2B40175

P932

Q34937231-3C51B710-50CD-4D1D-91E0-CF42F3665F65

P356

P1433

Clinical Infectious Diseases

P1476

Incomplete peripheral CD4+ cel ...... term antiretroviral treatment.

@en

P2093

Christina M R Kitchen

http://www.w3.org/2001/XMLSchema#string

Colleen F Kelley

http://www.w3.org/2001/XMLSchema#string

Heide M Crane

http://www.w3.org/2001/XMLSchema#string

James Willig

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Martin

http://www.w3.org/2001/XMLSchema#string

Mari Kitahata

http://www.w3.org/2001/XMLSchema#string

Michael Mugavero

http://www.w3.org/2001/XMLSchema#string

Michael Saag

http://www.w3.org/2001/XMLSchema#string

Peter W Hunt

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

CD4+ count-guided interruption of antiretroviral treatment

Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count.

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.

Immunological recovery and antiretroviral therapy in HIV-1 infection.

P304

787-794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/597093

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Benigno Rodriguez

Frederick M. Hecht

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23979629

http://www.w3.org/2001/XMLSchema#string

P698

19193107

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2720023

http://www.w3.org/2001/XMLSchema#string